search button

Short‑ and long‑term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years

  • Authors:
    • Xiaoxu Lu
    • Hui Wu
    • Jianhua Wang
    • Jing Xu

  • View Affiliations

  • Published online on: December 31, 2013     https://doi.org/10.3892/mco.2013.235
  • Pages: 297-301
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The most relevant treatment modalities in elderly patients with esophageal carcinoma (EC) remain a subject of debate. Combined definitive chemoradiotherapy (CRT) is currently widely accepted as a non‑surgical treatment for esophageal cancer. However, elderly patients were excluded from the majority of studies on CRT, or the proportion of elderly patients was relatively low in those studies and the number of available studies on the treatment of EC patients aged ≥75 years is limited. The aim of the present retrospective study was to analyze the safety and efficacy of CRT in patients aged ≥75 years in order to assess the short‑ and long‑term outcomes of CRT for elderly patients with EC. In this study, based on further refinement of patient age groups and analysis of the Charlson comorbidity score, we performed a statistical analysis of factors such as short‑term response, long‑term survival and toxicity reactions. The results of the analysis indicated that the treatment of patients with EC aged ≥75 years with radiotherapy (RT) and chemotherapy was effective. However, we recommend that customized treatment is based on the stratification of patients into different age groups and the Charlson score, as for patients aged ≥80 years a lower‑dose therapy may be more beneficial and for patients aged ≥85 years definitive CRT should be administered with greater caution.
View References

Related Articles

Journal Cover

March-April 2014
Volume 2 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 1.4
  • Ranked
    (total number of cites)
  • CiteScore: 2.8
  • CiteScore Rank: Q3: #250/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.55
  • SCImago Journal Rank (SJR): 0.446
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Lu X, Wu H, Wang J and Xu J: Short‑ and long‑term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years. Mol Clin Oncol 2: 297-301, 2014.
APA
Lu, X., Wu, H., Wang, J., & Xu, J. (2014). Short‑ and long‑term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years. Molecular and Clinical Oncology, 2, 297-301. https://doi.org/10.3892/mco.2013.235
MLA
Lu, X., Wu, H., Wang, J., Xu, J."Short‑ and long‑term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years". Molecular and Clinical Oncology 2.2 (2014): 297-301.
Chicago
Lu, X., Wu, H., Wang, J., Xu, J."Short‑ and long‑term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years". Molecular and Clinical Oncology 2, no. 2 (2014): 297-301. https://doi.org/10.3892/mco.2013.235